Thermogenic effect of an acute ingestion of a weight loss supplement

Journal of the International Society of Sports Nutrition (Impact Factor: 1.5). 01/2008; 6(1):1-9. DOI: 10.1186/1550-2783-6-1
Source: PubMed

ABSTRACT Background
The purpose of this study was to examine the acute effects of a weight loss supplement on resting oxygen uptake (VO2), respiratory quotient (RQ), caloric expenditure (kcal), heart rate (HR), and blood pressure (BP) in healthy and physically active individuals.

Ten subjects (5 male, 5 female; 20.2 ± 1.2 y; 172.2 ± 8.9 cm; 71.5 ± 17.2 kg; 17.3 ± 2.6% body fat) underwent two testing sessions administered in a randomized and double-blind fashion. During each session, subjects reported to the Human Performance Laboratory after at least 3-h post-absorptive state and were provided either 3 capsules of the weight loss supplement (SUP), commercially marketed as Meltdown® or 3 capsules of a placebo (P). Subjects then rested in a semi-recumbent position for three hours. VO2 and HR were determined every 5 min during the first 30 min and every 10 min during the next 150 min. BP was determined every 15 min during the first 30 min and every 30 min thereafter. The profile of mood states was assessed every 30 min.

Area under the curve analysis revealed a significant 28.9% difference in VO2 between SUP and P for the three hour study period. In addition, a significant difference in energy expenditure was also seen between SUP (1.28 ± 0.33 kcal·min-1) and P (1.00 ± 0.32 kcal·min-1). A trend (p = 0.06) towards a greater utilization of stored fat as an energy source was also demonstrated (0.78 ± 0.23 kcal·min-1 and 0.50 ± 0.38 kcal·min-1 in P and SUP, respectively). Significant elevations in HR were seen during hours two and three of the study, and significantly higher average systolic BP was observed between SUP (118.0 ± 7.3 mmHg) and P (111.4 ± 8.2 mmHg). No significant differences were seen in diastolic blood pressure at any time point. Significant increases in tension and confusion were seen in SUP.

Results indicate a significant increase in energy expenditure in young, healthy individuals following an acute ingestion of a weight loss supplement. In addition, ingestion of this supplement appears modify mood and elevate HR and systolic BP following ingestion.

Download full-text


Available from: Jay R Hoffman, Jan 24, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To compare the resting energy expenditure (REE, kcal/d) measured to the disposable equation of literature and to associate this to body composition. Twenty-eight sedentary women were volunteers [weight: 79 +/- 12 kg; stature: 164 +/- 5 cm; age: 36 +/- 11 years; body mass index (BMI, kg/m(2)): 29 +/- 4]. The body composition was estimated with anthropometry methods; REE was measured by indirect calorimetry and was estimated by the main equations of the literature. Equations were developed to estimate REE and the best of them was REE-Our. The different time of harvest produced a similar result to REE measured. The Harris and Benedict, FAO/WHO/UNO only weight, and weight plus height, Schofield and REE-Our equations results were statistically similar to REE measured. The Siervo and Falconi, Schofield and Henry and Rees equations did not have correlation with the measured calorimetry. The best-isolated predictor of the REE was the body mass and the best association when adjusted to unit (kg) was lean body mass. The equation developed in the present work was: REE(kcal/d)= 21837 - 14,448 * Weight(kg) + 54,963 * Lean Mass(kg)--9,341 * Stature(cm)--4,349 * Age(years)--19753 * Body Density(g/ml). The REE prediction equations can prompt to errors and seem to be population specific. The best prediction result was with the equation developed with anthropometrics variables of the volunteers (measured= 1617 +/- 237 kcal/d; REE-Our= 1616 +/- 167 kcal/d).
    Arquivos Brasileiros de Endocrinologia & Metabologia 01/2007; 50(6):1050-8. · 0.68 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Dietary supplements targeting fat loss and increased thermogenesis are prevalent within the sport nutrition/weight loss market. While some isolated ingredients have been reported to be efficacious when used at high dosages, in particular in animal models and/or via intravenous delivery, little objective evidence is available pertaining to the efficacy of a finished product taken by human subjects in oral form. Moreover, many ingredients function as stimulants, leading to increased hemodynamic responses. The purpose of this investigation was to determine the effects of a finished dietary supplement on plasma catecholamine concentration, markers of lipolysis, metabolic rate, and hemodynamics. Methods Ten resistance trained men (age = 27 ± 4 yrs; BMI = 25 ± 3 kg· m-2; body fat = 9 ± 3%; mean ± SD) ingested a dietary supplement (Meltdown®, Vital Pharmaceuticals) or a placebo, in a random order, double blind cross-over design, with one week separating conditions. Fasting blood samples were collected before, and at 30, 60, and 90 minutes post ingestion and were assayed for epinephrine (EPI), norepinephrine (NE), glycerol, and free fatty acids (FFA). Area under the curve (AUC) was calculated for all variables. Gas samples were collected from 30–60 minutes post ingestion for measurement of metabolic rate. Heart rate and blood pressure were recorded at all blood collection times. Results AUC was greater for the dietary supplement compared to the placebo for NE (1332 ± 128 pg·mL-1·90 min-1 vs. 1003 ± 133 pg·mL-1·90 min-1; p = 0.03), glycerol (44 ± 3 μg·mL-1·90 min-1 vs. 26 ± 2 μg·mL-1·90 min-1; p < 0.0001), and FFA (1.24 ± 0.17 mmol·L-1·90 min-1 vs. 0.88 ± 0.12 mmol·L-1·90 min-1; p = 0.0003). No difference between conditions was noted for EPI AUC (p > 0.05). For all variables, values were highest at 90 minutes post ingestion. Total kilocalorie expenditure during the 30 minute collection period was 29.6% greater (p = 0.02) for the dietary supplement (35 ± 3 kcal) compared to placebo (27 ± 2 kcal). A condition main effect was noted for systolic blood pressure (p = 0.04), with values increasing from 117 ± 2 mmHg to 123 ± 2 mmHg with the dietary supplement, while remaining unchanged for placebo. No other hemodynamic changes were noted (p > 0.05). Conclusion The dietary supplement results in an acute increase in plasma NE and markers of lipolysis, as well as metabolic rate. This occurs without altering hemodynamic variables in a clinically significant manner. Intervention studies to determine the impact of this dietary supplement on weight/fat loss are warranted.
    Journal of the International Society of Sports Nutrition 01/2009; 6(1):1-9. DOI:10.1186/1550-2783-6-4 · 1.50 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Correction to Richard J Bloomer, Kelsey H Fisher-Wellman, Kelley G Hammond, Brian K Schilling, Adrianna A Weber and Bradford J Cole: Dietary supplement increases plasma norepinephrine, lipolysis, and metabolic rate in resistance trained men. Journal of the International Society of Sports Nutrition 2009, 6: 4.
    Journal of the International Society of Sports Nutrition 05/2009; 6:10. DOI:10.1186/1550-2783-6-10 · 1.50 Impact Factor